MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN
weakening of immune status under the influence of some diseases or types of treatment could result in the activation of the present latent tuberculosis infection (LTBI). Recently it was suggested to use the immunoenzymometric interferon-gamma tests, T-SPOT.TB among them, but their costs are substant...
Saved in:
| Main Authors: | V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-03-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/73 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors for negative T-SPOT.TB assay results in patients with confirmed active tuberculosis: A retrospective study
by: Yanwan Shangguan, et al.
Published: (2020-11-01) -
Recombinant in vitro test T-SPOT.TB as a screening method for early diagnosis of tuberculosis infection
by: E. P. Eremenko, et al.
Published: (2020-05-01) -
Association between the extent of intrapulmonary spread on chest CT and false-negative results of T-SPOT.TB in pulmonary tuberculosis: a retrospective study
by: Ryo Sato, et al.
Published: (2025-03-01) -
Advancement in diagnostic approaches for latent tuberculosis: distinguishing recent from remote infections
by: Yi En Ding, et al.
Published: (2025-04-01) -
Results of a tuberculin skin testing survey in Albania
by: Hasan Hafizi, et al.
Published: (2014-03-01)